BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sidorkiewicz M, Jais JP, Tralhao G, Morosan S, Giannini C, Brezillon N, Soussan P, Delpuech O, Kremsdorf D. Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World J Gastroenterol 2008; 14(4): 574-581 [PMID: 18203290 DOI: 10.3748/wjg.14.574]
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/574.htm
Number Citing Articles
1
Hans Helmut Niller, Eva Ay, Ferenc Banati, Anett Demcsák, Maria Takacs, Janos Minarovits. Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV‐associated neoplasmsReviews in Medical Virology 2016; 26(1): 57 doi: 10.1002/rmv.1864
2
Arvin Medhat, Alla Arzumanyan, Mark A. Feitelson. Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinomaOncotarget 2021; 12(24): 2421 doi: 10.18632/oncotarget.28077
3
Yan Zhang, Jie Zhang, Huiming Sheng, Haichuan Li, Rongfang Wang. Advances in Clinical Chemistry 2019; 90: 25 doi: 10.1016/bs.acc.2019.01.002
4
Eun-Sook Park, Mehrangiz Dezhbord, Ah Ram Lee, Bo Bae Park, Kyun-Hwan Kim. Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular CarcinomaCancers 2022; 14(15): 3566 doi: 10.3390/cancers14153566
5
Mark A Feitelson, Helena MGPV Reis, Jingbo Pan, Marcy Clayton, Bill Sun, N Lale Satiroglu-Tufan, Zhaorui Lian. HBV X protein: elucidating a role in oncogenesisFuture Virology 2008; 3(5): 455 doi: 10.2217/17460794.3.5.455
6
Da-Li Zheng, Li Zhang, Na Cheng, Xiao Xu, Qing Deng, Xiao-Mei Teng, Ke-Sheng Wang, Xin Zhang, Jian Huang, Ze-Guang Han. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3AJournal of Hepatology 2009; 50(2): 377 doi: 10.1016/j.jhep.2008.10.019
7
Wei Sun, Fan Zhong, Lianteng Zhi, Gangqiao Zhou, Fuchu He. Systematic -omics analysis of HBV-associated liver diseasesCancer Letters 2009; 286(1): 89 doi: 10.1016/j.canlet.2008.12.002